278
Views
6
CrossRef citations to date
0
Altmetric
Review

Radium-223 chloride: a potential new treatment for castration-resistant prostate cancer patients with metastatic bone disease

, , &
Pages 1-14 | Published online: 08 Jan 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (6)

Inês A. Marques, Ana M. Abrantes, Ana S. Pires, Ana R. Neves, Francisco J. Caramelo, Tiago Rodrigues, Paulo Matafome, Edgar Tavares-da-Silva, Ana C. Gonçalves, Cristiana C. Pereira, João P. Teixeira, Raquel Seiça, Grancinda Costa, Arnaldo Figueiredo & Maria F. Botelho. (2021) Kinetics of radium-223 and its effects on survival, proliferation and DNA damage in lymph-node and bone metastatic prostate cancer cell lines. International Journal of Radiation Biology 97:5, pages 714-726.
Read now
Francisco D. C. Guerra Liberal, Adriana Alexandre S. Tavares & João Manuel R. S. Tavares. (2017) Computational modeling of radiobiological effects in bone metastases for different radionuclides. International Journal of Radiation Biology 93:6, pages 627-636.
Read now
Sandro Barni. (2016) 4th Mediterranean Multidisciplinary Course on Iron Anemia April 29th–30th 2016, Madrid, Spain. Expert Review of Hematology 9:sup1, pages 1-42.
Read now
Deborah Mukherji, Imane El Dika, Sally Temraz, Mohammed Haidar & Ali Shamseddine. (2014) Evolving treatment approaches for the management of metastatic castration-resistant prostate cancer – role of radium-223. Therapeutics and Clinical Risk Management 10, pages 373-380.
Read now
Sergio Bracarda, Michele Sisani, Francesca Marrocolo, Alketa Hamzaj, Sabrina Del Buono & Amelia Altavilla. (2014) Clinical implications for a treatment algorithm and differential indication to hormone therapy and chemotherapy options in metastatic castrate-resistant prostate cancer: a personal view. Expert Review of Anticancer Therapy 14:11, pages 1283-1294.
Read now
Pavlos Msaouel, Gayathri Nandikolla, Spyros G Pneumaticos & Michael Koutsilieris. (2013) Bone microenvironment-targeted manipulations for the treatment of osteoblastic metastasis in castration-resistant prostate cancer. Expert Opinion on Investigational Drugs 22:11, pages 1385-1400.
Read now